NAIMS Workshop 2020
Evidence for Translation of MRI to the Clinic: The next generation of MRI use in the MS Clinic
West Palm Beach, FL | February 26, 2020
Introduction
8:30 - 8:40 | Welcome and Introduction Roland Henry, University of California, San Francisco |
Session 1: Clinically Relevant MRI Prognostic Markers
Moderators: Corree Laule, The University of British Columbia; Susie Huang, Harvard Medical School
8:40 - 9:10 | Prognostic Value of the Clinical Radiology Report David Li, University of British Columbia |
9:10 - 9:40 | Defining Clinical Relevance for Translation to Practice Nancy Sicotte, Cedars Sinai |
9:40 - 10:00 | Session 1 Speaker Panel Discussion |
Session 2: Potentially Clinically Relevant MRI Prognostic Markers: Atrophy
Moderators: Susan Gauthier, Weill Cornell Medicine; Roland Henry, University of California, San Francisco
10:20 - 10:40 | Does Brain Atrophy Predict Disease Progression Elizabeth Fisher, Biogen |
10:40 - 11:00 | Does Spinal Cord Atrophy Predict Disease Progression Jiwon Oh, University of Toronto |
11:00 - 11:20 | Session 2 Speaker Panel Discussion |
Session 3: Potentially Clinically Relevant MRI Prognostic Markers: Lesions
Moderators: Corree Laule, The University of British Columbia; Susie Huang, Harvard Medical School
11:20 - 11:35 | The Case for QSM/SWI Susan Gauthier, Weill Cornell Medicine |
11:35 - 11:50 | The Case for Leptomeningeal Enhancement Jon Zurawski, Brigham and Women's Hospital |
11:50 - 12:05 | The Case for Grey Matter Lesions Constantina Treaba, Massachusetts General Hospital |
12:05 - 12:20 | The Case for Disappearing White Matter Lesions Robert Zivadinov, University at Buffalo |
12:20 - 12:35 | What Advanced MS Imaging Markers Should Make It to Your Workstation, and How Might That Look? Daniel Reich, National Institutes of Health |
12:35 - 12:50 | Session 3 Panel Discussion |
Session 4: Potential for Precision: Statistical Aspects
Moderators: Christina Azevedo, University of Southern California; Roland Henry, University of California, San Francisco
14:00 - 14:40 | Clinical Precision: Experience from Brain Atropy Nicola de Stefano, University of Siena, Italy |
14:40 - 15:20 | The Role of Reference Values and Knowledge Integration to Prognostic Value Taki Shinohara, University of Pennsylvania |
15:20 - 15:40 | Session 4 Panel Discussion |
Session 5: The Ecosystem for Translation to Clinical Practice
Moderators: William Rooney, Oregon Health Sciences University; David Li, University of British Columbia
16:00 - 16:30 | The Infrastructure for Delivering Quantitative Metrics in the Clinic Michel Bilello, University of Pennsylvania |
16:30 - 17:00 | Regulatory and Insurance Issues Diane Stephenson, Critical Path Institute |
17:00 - 17:20 | Session 5 Panel Discussion |
Open Discussion and Wrap-Up
17:20 - 17:50 | What are the next steps? Roland Henry, University of California, San Francisco; Corree Laule, The University of British Columbia; Susie Huang, Harvard Medical School |
Poster Viewing
18:00 - 20:00 | NAIMS Poster Session |